Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Operating Income
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
Operating Income
¥814.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Income
¥787.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
See Also
What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Operating Income?
Operating Income
814.8m
CNY
Based on the financial report for Dec 31, 2023, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Operating Income amounts to 814.8m CNY.
What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
9%
Over the last year, the Operating Income growth was 20%. The average annual Operating Income growth rates for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd have been 12% over the past three years , 12% over the past five years , and 9% over the past ten years .